Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia

References

• Baker, A., Richmond, R., Haile, M., Lewin, T. J., Carr, V. J., Taylor, R. L., … Wilhelm, K. (2006). A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163(11), 1934–1942. doi:10.1176/appi.ajp.163.11.1934
   PubMed Web of Science ®Google Scholar
• Baker, T. B., Breslau, N., Covey, L., & Shiffman, S. (2012). DSM criteria for tobacco use disorder and tobacco withdrawal: A critique and proposed revisions for DSM-5. Addiction, 107(2), 263–275. doi:10.1111/j.1360-0443.2011.03657.x
   PubMed Web of Science ®Google Scholar
• Barnes, M., Lawford, B. R., Burton, S. C., Heslop, K. R., Noble, E. P., Hausdorf, K., & Young, R. M. (2006). Smoking and schizophrenia: Is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Australian and New Zealand Journal of Psychiatry, 40(6–7), 575–580. doi:10.1111/j.1440-1614.2006.01841.x
   PubMed Web of Science ®Google Scholar
• Berger, S. P., Hall, S., Mickalian, J. D., Reid, M. S., Crawford, C. A., Delucchi, K., & Carr, K. (1996). Haloperidol antagonism of cue-elicited cocaine craving. Lancet, 347(9000), 504–508. doi:10.1016/S0140-6736(96)91139-3
   PubMed Web of Science ®Google Scholar
• Berlin, I., Singleton, E. G., & Heishman, S. J. (2013). Predicting smoking relapse with a multidimensional versus a single-item tobacco craving measure. Drug and Alcohol Dependence, 132(3), 513–520. doi:10.1016/j.drugalcdep.2013.03.017
   PubMed Web of Science ®Google Scholar
• Bolt, D. M., Piper, M. E., Theobald, W. E., & Baker, T. B. (2012). Why two smoking cessation agents work better than one: Role of craving suppression. Jounal of Consulting and Clinical Psychology, 80(1), 54–65. doi:10.1037/a0026366
   PubMed Web of Science ®Google Scholar
• Brauer, L. H., Cramblett, M. J., Paxton, D. A., & Rose, J. E. (2001). Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes. Psychopharmacology (Berl), 159(1), 31–37. doi:10.1007/s002130100894
   PubMed Web of Science ®Google Scholar
• Casey, M., Adamson, G., Shevlin, M., & McKinney, A. (2012). The role of craving in AUDs: dimensionality and differential functioning in the DSM-5. Drug and Alcohol Dependence, 125(1–2), 75–80. doi:10.1016/j.drugalcdep.2012.03.019
   PubMed Web of Science ®Google Scholar
• Caskey, N. H., Jarvik, M. E., & Wirshing, W. C. (1999). The effects of dopaminergic D2 stimulation and blockade on smoking behavior. Experimental and Clinical Psychopharmacology, 7(1), 72–78. doi:10.1037/1064-1297.7.1.72
   PubMed Web of Science ®Google Scholar
• Caskey, N. H., Jarvik, M. E., Wirshing, W. C., Madsen, D. C., Iwamoto-Schaap, P. N., Eisenberger, N. I., … Olmstead, R. E. (2002). Modulating tobacco smoking rates by dopaminergic stimulation and blockade. Nicotine and Tobacco Research, 4(3), 259–266. doi:10.1080/14622200210153830
   PubMedGoogle Scholar
• Chau, D. T., Roth, R. M., & Green, A. I. (2004). The neural circuitry of reward and its relevance to psychiatric disorders. [Review]. Current Psychiatry Reports, 6(5), 391–399. doi:10.1007/s11920-004-0026-8
   PubMedGoogle Scholar
• Chaves, L., & Shirakawa, I. (2008). Nicotine use in patients with schizophrenia evaluated by the Fagerstrom tolerance questionnaire: A descriptive analysis from a Brazilian sample. Revista Brasileira de Psiquiatria, 30(4), 350–352. doi:10.1590/S1516-44462008005000014
   PubMed Web of Science ®Google Scholar
• Combs, D. R., & Advokat, C. (2000). Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia. Schizophrenia Research, 46(2–3), 129–137. doi:10.1016/S0920-9964(00)00026-8
   PubMed Web of Science ®Google Scholar
• Dawe, S., Gerada, C., Russell, M. A., & Gray, J. A. (1995). Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology (Berl), 117(1), 110–115. doi:10.1007/BF02245105
   PubMed Web of Science ®Google Scholar
• de Leon, J., Armstrong, S. C., & Cozza, K. L. (2006). Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics, 47(1), 75–85. doi:10.1176/appi.psy.47.1.75
   PubMed Web of Science ®Google Scholar
• Donny, E. C., Griffin, K. M., Shiffman, S., & Sayette, M. A. (2008). The relationship between cigarette use, nicotine dependence, and craving in laboratory volunteers. Nicotine and Tobacco Research, 10(5), 934–942. doi:10.1080/14622200802133681
   PubMed Web of Science ®Google Scholar
• Frankenburg, F. R., Zanarini, M. C., Kando, J., & Centorrino, F. (1998). Clozapine and body mass change. Biological Psychiatry, 43(7), 520–524. doi:10.1016/S0006-3223(97)00488-5
   PubMed Web of Science ®Google Scholar
• George, T. P., Sernyak, M. J., Ziedonis, D. M., & Woods, S. W. (1995). Effects of clozapine on smoking in chronic schizophrenic outpatients. Journal of Clinical Psychiatry, 56(8), 344–346.
   PubMed Web of Science ®Google Scholar
• Hasin, D. S. (2012). Introduction to DSM-5 criteria linked papers in drug and alcohol dependence. Drug and Alcohol Dependence, 122(1–2), 20–21. doi:10.1016/j.drugalcdep.2011.10.028
   PubMed Web of Science ®Google Scholar
• Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86(9), 1119–1127. doi:10.1111/j.1360-0443.1991.tb01879.x
   PubMedGoogle Scholar
• Heishman, S. J., Singleton, E. G., & Pickworth, W. B. (2008). Reliability and validity of a short form of the Tobacco Craving Questionnaire. Nicotine and Tobacco Research, 10(4), 643–651. doi:10.1080/14622200801908174
   PubMed Web of Science ®Google Scholar
• Herran, A., de Santiago, A., Sandoya, M., Fernandez, M. J., Diez-Manrique, J. F., & Vazquez-Barquero, J. L. (2000). Determinants of smoking behaviour in outpatients with schizophrenia. Schizophrenia Research, 41(2), 373–381. doi:10.1016/S0920-9964(99)00082-1
   PubMed Web of Science ®Google Scholar
• Hutchison, K. E., Rutter, M. C., Niaura, R., Swift, R. M., Pickworth, W. B., & Sobik, L. (2004). Olanzapine attenuates cue-elicited craving for tobacco. Psychopharmacology (Berl), 175(4), 407–413. doi:10.1007/s00213-004-1837-3
   PubMed Web of Science ®Google Scholar
• Indave, B. I., Minozzi, S., Pani, P. P., & Amato, L. (2016). Antipsychotic medications for cocaine dependence. The Cochrane Library, (3), CD006306. doi:10.1002/14651858.CD006306.pub3
   Google Scholar
• Kelly, D. L., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Boggs, D. L., … Dixon, L. (2011). Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bulletin, 37, 832–838. doi:10.1093/schbul/sbp152
   PubMed Web of Science ®Google Scholar
• Kelly, D. L., Raley, H. G., Lo, S., Wright, K., Liu, F., McMahon, R. P., … Heishman, S. J. (2012). Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophrenia Bulletin, 38(3), 543–551. doi:10.1093/schbul/sbq124
   PubMed Web of Science ®Google Scholar
• Kishi, T., Matsuda, Y., Iwata, N., & Correll, C. U. (2013). Antipsychotics for cocaine or psychostimulant dependence: Systematic review and meta-analysis of randomized, placebo-controlled trials. The Journal of Clinical Psychiatry, 74(12), 1169–1180.
   Web of Science ®Google Scholar
• Kishi, T., Sevy, S., Chekuri, R., & Correll, C. U. (2013). Antipsychotics for primary alcohol dependence: A systematic review and meta-analysis of placebo-controlled trials. The Journal of Clinical Psychiatry, 74(7), 642–654.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Bao, Y.-p., Sun, H.-q., Beveridge, T. J., Li, S.-x., Di, X.-l., & Lu, L. (2010). Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers. Journal of Clinical Psychopharmacology, 30(4), 373–380. doi:10.1097/JCP.0b013e3181e78a2b
   PubMed Web of Science ®Google Scholar
• Liu, Y., Sun, H. Q., Bao, Y. P., Li, S. X., Beveridge, T. J., Di, X. L., … Lu, L. (2009). Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers. Drug and Alcohol Dependence, 101(1–2), 42–52. doi:10.1016/j.drugalcdep.2008.10.024
   PubMed Web of Science ®Google Scholar
• Lo, S., Heishman, S. J., Raley, H., Wright, K., Wehring, H. J., Moolchan, E. T., … Kelly, D. L. (2011). Tobacco craving in smokers with and without schizophrenia. Schizophrenia Research, 127(1–3), 241–245. doi:10.1016/j.schres.2010.06.017
   PubMed Web of Science ®Google Scholar
• Mackowick, K. M., Heishman, S. J., Wehring, H. J., Liu, F., McMahon, R. P., & Kelly, D. L. (2012). Illicit drug use in heavy smokers with and without schizophrenia. Schizophrenia Research, 139(1–3), 194–200. doi:10.1016/j.schres.2012.04.012
   PubMed Web of Science ®Google Scholar
• Mahler, S. V., & de Wit, H. (2005). Effects of haloperidol on reactions to smoking cues in humans. Behavioural Pharmacology, 16(2), 123–126. doi:10.1097/00008877-200503000-00008
   PubMed Web of Science ®Google Scholar
• Martinotti, G., Orsolini, L., Fornaro, M., Vecchiotti, R., De Berardis, D., Iasevoli, F., … Di Giannantonio, M. (2016). Aripiprazole for relapse prevention and craving in alcohol use disorder: Current evidence and future perspectives. Expert Opinion on Investigational Drugs, 25(6), 719–728.
   PubMed Web of Science ®Google Scholar
• McEvoy, J., Freudenreich, O., McGee, M., VanderZwaag, C., Levin, E., & Rose, J. (1995). Clozapine decreases smoking in patients with chronic schizophrenia. Biological Psychiatry, 37(8), 550–552. doi:10.1016/0006-3223(94)00365-A
   PubMed Web of Science ®Google Scholar
• McEvoy, J. P., Freudenreich, O., Levin, E. D., & Rose, J. E. (1995). Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology (Berl), 119(1), 124–126. doi:10.1007/BF02246063
   PubMed Web of Science ®Google Scholar
• McEvoy, J. P., Freudenreich, O., & Wilson, W. H. (1999). Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological Psychiatry, 46(1), 125–129. doi:10.1016/S0006-3223(98)00377-1
   PubMed Web of Science ®Google Scholar
• Moeller-Saxone, K. (2008). Cigarette smoking and interest in quitting among consumers at a psychiatric disability rehabilitation and support service in Victoria. Australian and New Zealand Journal of Public Health, 32(5), 479–481. doi:10.1111/j.1753-6405.2008.00283.x
   PubMed Web of Science ®Google Scholar
• Nestler, E. J. (2005). Is there a common molecular pathway for addiction? Nature Neuroscience, 8(11), 1445–1449. doi:10.1038/nn1578
   PubMed Web of Science ®Google Scholar
• Procyshyn, R. M., Tse, G., Sin, O., & Flynn, S. (2002). Concomitant clozapine reduces smoking in patients treated with risperidone. [Comparative Study]. European Neuropsychopharmacology, 12(1), 77–80. doi:10.1016/S0924-977X(01)00130-4
   PubMed Web of Science ®Google Scholar
• Sayers, S. L., Campbell, E. C., Kondrich, J., Mann, S. C., Cornish, J., O'Brien, C., & Caroff, S. N. (2005). Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol. The Journal of Nervous and Mental Disease, 193(6), 379–386. doi:10.1097/01.nmd.0000165089.14736.bf
   PubMed Web of Science ®Google Scholar
• Steinberg, M. L., Williams, J. M., Steinberg, H. R., Krejci, J. A., & Ziedonis, D. M. (2005). Applicability of the Fagerstrom Test for Nicotine Dependence in smokers with schizophrenia. Addictive Behaviors, 30(1), 49–59. doi:10.1016/j.addbeh.2004.04.012
   PubMed Web of Science ®Google Scholar
• Tidey, J. W., Colby, S. M., & Xavier, E. M. (2014). Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia. Nicotine & Tobacco Research, 16(3), 326–334. doi:10.1093/ntr/ntt152
   PubMed Web of Science ®Google Scholar
• Tidey, J. W., & Williams, J. (2007). Clinical indices of tobacco use in people with schizophrenia. Journal of Dual Diagnosis, 3(3–4), 79–98. doi:10.1300/J374v03n03_07
   Google Scholar
• USDHHS. (2011). Mental Health Services Administration.(2009). Results from the 2008 National Survey on Drug Use and Health: National Findings. (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434). Rockville, MD: Office of Applied Studies.
   Google Scholar
• Winterer, G. (2010). Why do patients with schizophrenia smoke? Current Opinion in Psychiatry, 23(2), 112–119. doi:10.1097/YCO.0b013e3283366643
   PubMed Web of Science ®Google Scholar